These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2829289)

  • 1. The effects of cholinergic drugs upon recognition memory in rats.
    Huston AE; Aggleton JP
    Q J Exp Psychol B; 1987 Nov; 39(4):297-314. PubMed ID: 2829289
    [No Abstract]   [Full Text] [Related]  

  • 2. Cholinergic drug effects on a delayed conditional discrimination task in the rat.
    Herremans AH; Hijzen TH; Olivier B; Slangen JL
    Behav Neurosci; 1995 Jun; 109(3):426-35. PubMed ID: 7662153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effects of cholinergic agonists on memory.
    Olton DS; Raffaele KC
    NIDA Res Monogr; 1990; 97():37-47. PubMed ID: 2247139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human memory and the cholinergic system. A relationship to aging?
    Drachman DA; Leavitt J
    Arch Neurol; 1974 Feb; 30(2):113-21. PubMed ID: 4359364
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of single administration of scopolamine, physostigmine and their combination on biogenic amine levels in rat brain.
    Hrbek J; Rypka M; Hrbek J
    Acta Univ Palacki Olomuc Fac Med; 1989; 121():271-5. PubMed ID: 2533807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The search for the chemistry of memory: recent trends and the logic of investigation in the role of cholinergic and adrenergic transmitters.
    Biederman GB
    Prog Neurobiol; 1975; 2():291-307. PubMed ID: 169545
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of scopolamine and physostigmine on recognition memory in monkeys with ibotenic-acid lesions of the nucleus basalis of Meynert.
    Aigner TG; Mitchell SJ; Aggleton JP; DeLong MR; Struble RG; Price DL; Wenk GL; Mishkin M
    Psychopharmacology (Berl); 1987; 92(3):292-300. PubMed ID: 3114781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perceptual bisection in rats: the effects of physostigmine, scopolamine and pirenzepine.
    Shurtleff D; Raslear TG; Genovese RF; Simmons L
    Physiol Behav; 1992 Feb; 51(2):381-90. PubMed ID: 1557449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholinergic transmission and electrophysiological investigation of the human visual system.
    Sannita WG
    Electroencephalogr Clin Neurophysiol Suppl; 1995; 44():156-60. PubMed ID: 7649017
    [No Abstract]   [Full Text] [Related]  

  • 10. MK-801 impairs recognition memory in rhesus monkeys: comparison with cholinergic drugs.
    Ogura H; Aigner TG
    J Pharmacol Exp Ther; 1993 Jul; 266(1):60-4. PubMed ID: 8331575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ontogenetic aspects of central cholinergic involvement in spontaneous alternation behavior.
    Egger GJ; Livesey PJ; Dawson RG
    Dev Psychobiol; 1973 Jul; 6(4):289-99. PubMed ID: 4793359
    [No Abstract]   [Full Text] [Related]  

  • 12. Relearning at different times after training as affected by centrally and peripherally acting cholinergic drugs in the mouse.
    Squire LR; Glick SD; Goldfarb J
    J Comp Physiol Psychol; 1971 Jan; 74(1):41-5. PubMed ID: 5163699
    [No Abstract]   [Full Text] [Related]  

  • 13. Central cholinergic involvement in working memory: effects of scopolamine on continuous nonmatching and discrimination performance in the rat.
    Spencer DG; Pontecorvo MJ; Heise GA
    Behav Neurosci; 1985 Dec; 99(6):1049-65. PubMed ID: 3843539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cholinergic agent physostigmine enhances short-term-memory-based performance in the developing rat.
    Castro CA; Paylor R; Moye TB; Rudy JW
    Behav Neurosci; 1990 Apr; 104(2):390-3. PubMed ID: 2346631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a neurotensin analogue (PD149163) and antagonist (SR142948A) on the scopolamine-induced deficits in a novel object discrimination task.
    Azmi N; Norman C; Spicer CH; Bennett GW
    Behav Pharmacol; 2006 Jun; 17(4):357-62. PubMed ID: 16914954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of post-trial injections of scopolamine and eserine on acquisition of a simultaneous brightness discrimination.
    Miller L; Drew WG; McCoy DF
    Psychol Rep; 1971 Dec; 29(3):1147-52. PubMed ID: 5139351
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of the effects of bifemelane hydrochloride and indeloxazine hydrochloride on scopolamine hydrobromide-induced impairment in radial maze performance.
    Ogawa N; Haba K; Sora YH; Higashida A; Sato H; Ogawa S
    Clin Ther; 1988; 10(6):704-11. PubMed ID: 3219685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of scopolamine on morphine-induced conditioned place preference in mice.
    Tan H; Liu N; Wilson FA; Ma Y
    Addict Biol; 2007 Sep; 12(3-4):463-9. PubMed ID: 17678506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scopolamine impairs performance of a place and cue task in rats.
    Okaichi H; Jarrard LE
    Behav Neural Biol; 1982 Jul; 35(3):319-25. PubMed ID: 7181822
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of physostigmine and scopolamine on operant brightness discrimination in the rat.
    Leaton RN; Kreindler M
    Physiol Behav; 1972 Jul; 9(1):121-3. PubMed ID: 5080149
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.